RhumbLine Advisers’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-32,999
| Closed | -$144K | – | 4143 |
|
2025
Q1 | $144K | Buy |
32,999
+1,332
| +4% | +$5.82K | ﹤0.01% | 3272 |
|
2024
Q4 | $148K | Sell |
31,667
-662
| -2% | -$3.09K | ﹤0.01% | 3341 |
|
2024
Q3 | $227K | Buy |
32,329
+1,508
| +5% | +$10.6K | ﹤0.01% | 3174 |
|
2024
Q2 | $211K | Buy |
30,821
+30,528
| +10,419% | +$209K | ﹤0.01% | 3198 |
|
2024
Q1 | $4.14K | Sell |
293
-1
| -0.3% | -$14 | ﹤0.01% | 4004 |
|
2023
Q4 | $2.21K | Hold |
294
| – | – | ﹤0.01% | 4085 |
|
2023
Q3 | $4.41K | Hold |
294
| – | – | ﹤0.01% | 4006 |
|
2023
Q2 | $4.67K | Buy |
+294
| New | +$4.67K | ﹤0.01% | 4103 |
|
2022
Q2 | – | Sell |
-11,921
| Closed | -$156K | – | 3089 |
|
2022
Q1 | $156K | Sell |
11,921
-967
| -8% | -$12.7K | ﹤0.01% | 2809 |
|
2021
Q4 | $227K | Sell |
12,888
-28
| -0.2% | -$493 | ﹤0.01% | 2799 |
|
2021
Q3 | $280K | Buy |
12,916
+211
| +2% | +$4.57K | ﹤0.01% | 2794 |
|
2021
Q2 | $445K | Buy |
12,705
+1,760
| +16% | +$61.6K | ﹤0.01% | 2610 |
|
2021
Q1 | $1.08M | Sell |
10,945
-879
| -7% | -$86.7K | ﹤0.01% | 2157 |
|
2020
Q4 | $1.28M | Buy |
11,824
+859
| +8% | +$93.1K | ﹤0.01% | 2036 |
|
2020
Q3 | $1.13M | Sell |
10,965
-872
| -7% | -$89.8K | ﹤0.01% | 1943 |
|
2020
Q2 | $2.47M | Buy |
11,837
+3,449
| +41% | +$720K | ﹤0.01% | 1608 |
|
2020
Q1 | $820K | Buy |
8,388
+1,066
| +15% | +$104K | ﹤0.01% | 1970 |
|
2019
Q4 | $843K | Buy |
7,322
+68
| +0.9% | +$7.83K | ﹤0.01% | 2159 |
|
2019
Q3 | $395K | Sell |
7,254
-13
| -0.2% | -$708 | ﹤0.01% | 2429 |
|
2019
Q2 | $864K | Sell |
7,267
-436
| -6% | -$51.8K | ﹤0.01% | 2118 |
|
2019
Q1 | $404K | Sell |
7,703
-87
| -1% | -$4.56K | ﹤0.01% | 2415 |
|
2018
Q4 | $245K | Buy |
7,790
+2,308
| +42% | +$72.6K | ﹤0.01% | 2635 |
|
2018
Q3 | $332K | Sell |
5,482
-25
| -0.5% | -$1.51K | ﹤0.01% | 2468 |
|
2018
Q2 | $292K | Buy |
+5,507
| New | +$292K | ﹤0.01% | 2546 |
|
2017
Q2 | – | Sell |
-2,870
| Closed | -$78K | – | 2922 |
|
2017
Q1 | $78K | Buy |
2,870
+887
| +45% | +$24.1K | ﹤0.01% | 2795 |
|
2016
Q4 | $58K | Sell |
1,983
-494
| -20% | -$14.4K | ﹤0.01% | 2821 |
|
2016
Q3 | $102K | Buy |
2,477
+50
| +2% | +$2.06K | ﹤0.01% | 2805 |
|
2016
Q2 | $77K | Buy |
2,427
+573
| +31% | +$18.2K | ﹤0.01% | 2942 |
|
2016
Q1 | $96K | Buy |
1,854
+10
| +0.5% | +$518 | ﹤0.01% | 2901 |
|
2015
Q4 | $176K | Buy |
1,844
+88
| +5% | +$8.4K | ﹤0.01% | 2837 |
|
2015
Q3 | $145K | Buy |
1,756
+68
| +4% | +$5.62K | ﹤0.01% | 2877 |
|
2015
Q2 | $274K | Buy |
1,688
+1,008
| +148% | +$164K | ﹤0.01% | 2718 |
|
2015
Q1 | $275K | Buy |
680
+268
| +65% | +$108K | ﹤0.01% | 2661 |
|
2014
Q4 | $222K | Buy |
+412
| New | +$222K | ﹤0.01% | 2748 |
|